Research Article
Perinatal Outcomes in HIV Positive Pregnant Women with Concomitant Sexually Transmitted Infections
Table 3
Perinatal and neonatal outcomes in HIV+ women with and without concomitant sexually transmitted infections.
| Outcomes | STI+
| STI−
| Total
| OR 95% CI | value |
| Preterm birth | | | | | | + | 57 (21.4%) | 21 (14.2%) | 78 (18.8%) | 1.65 (0.96–2.85) | 0.073 | − | 209 (78.6%) | 127 (85.8%) | 336 (81.2%) | Spontaneous preterm birth | | | | | | + | 48 (18.0%) | 14 (9.5%) | 62 (15.0%) | 2.11 (1.12–3.97) | 0.021 | − | 218 (82.0%) | 134 (90.5%) | 352 (85.0%) | Indicated preterm birth | | | | | | + | 9 (50.0%) | 7 (50.0%) | 16 (50.0%) | 1.00 (0.25–4.04) | 1.00 | − | 9 (50.0%) | 7 (50.0%) | 16 (50.0%) | Postpartum hemorrhage | | | | | | + | 20 (7.9%) | 8 (5.5%) | 28 (7.0%) | 1.47 (0.63–3.44) | 0.369 | − | 234 (92.1%) | 138 (94.5%) | 372 (93.0%) | Chorioamnionitis | | | | | | + | 10 (3.9%) | 2 (1.4%) | 12 (3.0%) | 2.91 (0.63–13.45) | 0.172 | − | 246 (96.1%) | 143 (98.6%) | 389 (97.0%) | Endometritis | | | | | | + | 12 (4.5%) | 3 (2.0%) | 15 (3.6%) | 2.28 (0.63–8.22) | 0.207 | − | 254 (95.5%) | 145 (98%) | 399 (96.4%) | Preeclampsia | | | | | | + | 13 (5.0%) | 10 (6.8%) | 23 (5.7%) | 0.73 (0.31–1.71) | 0.467 | − | 246 (95.0%) | 138 (93.2%) | 384 (94.3%) | Diabetes | | | | | | + | 10 (3.8%) | 6 (4.1%) | 16 (3.9%) | 0.94 (0.33–2.64)
| 0.905 | − | 252 (96.2%) | 142 (95.9%) | 394 (96.1%) | IUGR | | | | | | + | 6 (2.3%) | 1 (0.7%) | 7 (1.7%) | 3.41 (0.41–28.62) | 0.258 | − | 255 (97.7%) | 145 (99.3%) | 400 (98.3%) | Small for gestational age | | | | | | + | 23 (8.7%) | 12 (8.1%) | 35 (8.5%) | 1.08 (0.52–2.24) | 0.833 | − | 241 (91.3%) | 136 (91.9%) | 377 (91.5%) | 1 min Apgar <7 | | | | | | + | 33 (12.7%) | 19 (12.9%) | 52 (12.8%) | 0.98 (0.53–1.79) | 0.946 | − | 227 (87.3%) | 128 (87.1%) | 355 (87.2%) | 5 min Apgar <7 | | | | | | + | 33 (12.7%) | 19 (12.9%) | 52 (12.8%) | 0.98 (0.53–1.79) | 0.946 | − | 227 (87.3%) | 128 (87.1%) | 355 (87.2%) | NICU admission | | | | | | + | 52 (20.6%) | 21 (14.6%) | 73 (18.4%) | 1.52 (0.87–2.65) | 0.137 | − | 200 (79.4%) | 123 (85.4%) | 323 (81.7%) | RDS | | | | | | + | 19 (7.1%) | 3 (0.7%) | 22 (5.3%) | 3.72 (1.08–12.78) | 0.037 | − | 247 (92.9%) | 145 (99.3%) | 392 (94.7%) | Infant HIV | | | | | | + | 3 (1.1%) | 3 (2.0%) | 6 (1.4%) | 0.55 (0.11–2.77) | 0.469 | − | 263 (98.9%) | 145 (98.0%) | 408 (98.6%) |
|
|
IUGR-intrauterine growth restriction; NICU-neonatal intensive care unit; RDS-respiratory distress syndrome (as documented in pediatric note) OR odds ratio, CI confidence interval.
|